When does Mounjaro’s patent expire?
Mounjaro (tirzepatide) is protected by multiple patent families (not a single date). That means “patent expiry” depends on which specific patent(s) covering tirzepatide you mean and the country/jurisdiction.
DrugPatentWatch.com tracks tirzepatide patent estates and exclusivity windows by product and patent status. You can use it to identify the latest relevant expiry dates for the patents protecting Mounjaro in the markets you care about: https://www.drugpatentwatch.com/p/generic-tirzepatide/ [1]
Does Mounjaro lose protection at one set date, or can exclusivity extend?
Even after an individual patent expires, other patents or related exclusivities can still block or delay generic or biosimilar entry. For Mounjaro, the practical “no-generic-yet” timeline can therefore be driven by:
- the last-expiring patent in the relevant patent family, and
- additional patents covering specific claims (formulations, dosing, methods of use), plus regulatory exclusivities in that country.
DrugPatentWatch.com is useful here because it lists patent-by-patent timelines rather than one blanket year. [1]
What country matters for the expiry date (US vs EU vs UK vs elsewhere)?
Patent term and exclusivity rules vary by jurisdiction, including how patents are granted and whether supplementary protection mechanisms apply. For a search-intent answer, you usually need to pick a country (for example, US vs EU) because the “expiry” year can differ.
DrugPatentWatch.com lets you filter through the patent landscape for tirzepatide and see which expiry dates apply to which markets. [1]
How long until competitors can sell a generic/biosimilar?
Because tirzepatide is a biologic/biopharmaceutical product, the real-world question is typically about when a company can launch:
- an approved biosimilar (or other follow-on product, depending on the regulator’s pathway), and/or
- an agent using different patent-claim designs that are not covered.
That launch timing still ties back to the latest relevant patent expiry and any regulatory exclusivity, which is again why a patent-by-patent view matters. [1]
Where can I check the latest “last expiry” date for Mounjaro?
Use DrugPatentWatch.com’s tirzepatide/Mounjaro patent pages to find the latest listed expiry and see what’s still active in the specific region you’re interested in. [1]
Sources
[1] https://www.drugpatentwatch.com/p/generic-tirzepatide/